dipyridamole

(redirected from Aggrenox)
Also found in: Medical.
Related to Aggrenox: dipyridamole

di·pyr·id·a·mole

 (dī-pĭr′ĭ-də-mōl′, dī′pə-rĭd′ə-mōl′)
n.
A drug, C24H40N8O4, that acts as a coronary vasodilator and is used in the long-term treatment of angina pectoris and as an antiplatelet agent.

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
Translations

dipyridamole

n dipiridamol m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
(NYSE: LCI) today announced that it has commenced marketing Aspirin and Extended-Release Dipyridamole Capsules, 25 mg/200 mg, the therapeutic equivalent to the reference listed drug, Aggrenox Capsules, 25 mg/200 mg, of Boehringer Ingelheim Pharmaceuticals, Inc.
(NYSE: LCI), a company that develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications, announced on Tuesday that it has started marketing Aspirin and Extended-Release Dipyridamole Capsules, 25 mg/200 mg, the therapeutic equivalent to the reference listed drug, Aggrenox Capsules, 25 mg/200 mg, from Boehringer Ingelheim Pharmaceuticals Inc.
In a research note to investors, Steadman says ANI is set for several value-creating launches this year including the remaining Concerta strengths, a generic Aggrenox, a vancomycin oral solution and an undisclosed approved generic priority review product.
Judge Underhill of the District of Connecticut in Aggrenox, (136) Judge
Other antiplatelet drugs include clopidogrel (Plavix), ticlopidine (Ticlid), dipyridamole (Persantine) and Aggrenox, a combination of dipyridamole and aspirin.
Dipyridamole Vasodilator that Indications: Mostly used inhibits cGMP in combination with phosphodiesterase and other drugs such as cellular uptake of aspirin (Aggrenox) or adenosine.
The DOJ announced yesterday that Boehringer will pay $95 million to resolve the allegations that it improperly promoted its anti-stroke drug Aggrenox, its chronic obstructive pulmonary disease drugs Atrovent and Combivent, and its hypertension drug Micardis.
Dupont notes that antiplatelet drugs reduce the relative risk of stroke recurrence and that the combination of aspirin and dipyridamole (Aggrenox) seems to be more effective than aspirin alone.
The same is true for the temporary discontinuation of drugs such as aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), clopidogrel (Plavix), aspirin/ extended release dipyridamole (Aggrenox), and vitamin E.